Axonics Long Term Debt vs Deferred Long Term Liab Analysis

AXNX Stock

USD 70.28 0.01 0.01%

Axonics Modulation financial indicator trend analysis is way more than just evaluating Axonics Modulation prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Axonics Modulation is a good investment. Please check the relationship between Axonics Modulation Long Term Debt and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axonics Modulation Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Long Term Debt vs Deferred Long Term Liab

Long Term Debt vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Axonics Modulation Long Term Debt account and Deferred Long Term Liab. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Axonics Modulation's Long Term Debt and Deferred Long Term Liab is -0.6. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Axonics Modulation Technologies, assuming nothing else is changed. The correlation between historical values of Axonics Modulation's Long Term Debt and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Axonics Modulation Technologies are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Long Term Debt i.e., Axonics Modulation's Long Term Debt and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

-0.6

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Long Term Debt

Long-term debt is a debt that Axonics Modulation has held for over one year. Long-term debt appears on Axonics Modulation Technologies balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Axonics Modulation Technologies balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Axonics Modulation's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Axonics Modulation current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axonics Modulation Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Axonics Modulation's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 360.35 in 2024, whereas Selling General Administrative is likely to drop slightly above 25 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	10.1M	12.7M	13.4M	14.1M
Interest Income	40K	5.1M	16.2M	17.0M

Depreciation And Amortization Interest Income

Axonics Modulation fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Capital Lease Obligations	Other Current Assets	Other Stockholder Equity	Total Liab
Total Assets		0.64	0.87	0.92	0.94	0.67	0.92	0.66	-0.78	-0.96	0.83	0.81	0.88	0.69	0.36	0.86	0.97	0.97	0.92	0.84	-0.55	0.94	0.78	0.98	1.0	0.76
Short Long Term Debt Total	0.64		0.35	0.6	0.66	0.88	0.77	0.53	-0.64	-0.64	0.73	0.73	0.37	0.63	0.37	0.88	0.78	0.79	0.5	0.89	-0.83	0.65	0.65	0.78	0.66	0.12
Other Current Liab	0.87	0.35		0.92	0.8	0.41	0.77	0.45	-0.73	-0.84	0.62	0.72	0.76	0.61	0.17	0.64	0.85	0.77	0.83	0.62	-0.47	0.8	0.55	0.79	0.87	0.83
Total Current Liabilities	0.92	0.6	0.92		0.86	0.58	0.87	0.55	-0.82	-0.9	0.77	0.84	0.73	0.73	0.39	0.77	0.93	0.88	0.9	0.75	-0.66	0.86	0.68	0.89	0.92	0.78
Total Stockholder Equity	0.94	0.66	0.8	0.86		0.64	0.98	0.81	-0.71	-0.99	0.93	0.8	0.93	0.61	0.29	0.9	0.93	0.92	0.86	0.79	-0.6	1.0	0.91	0.94	0.94	0.69
Other Liab	0.67	0.88	0.41	0.58	0.64		0.71	0.28	-0.83	-0.64	0.55	0.86	0.41	0.86	0.57	0.89	0.77	0.84	0.5	0.95	-0.8	0.61	0.47	0.78	0.7	0.09
Net Tangible Assets	0.92	0.77	0.77	0.87	0.98	0.71		0.8	-0.74	-0.97	0.95	0.83	0.85	0.65	0.3	0.95	0.95	0.93	0.83	0.85	-0.71	0.98	0.9	0.95	0.93	0.62
Property Plant And Equipment Net	0.66	0.53	0.45	0.55	0.81	0.28	0.8		-0.21	-0.76	0.93	0.36	0.79	0.09	-0.05	0.65	0.63	0.6	0.62	0.46	-0.31	0.83	0.97	0.68	0.65	0.56
Net Debt	-0.78	-0.64	-0.73	-0.82	-0.71	-0.83	-0.74	-0.21		0.77	-0.54	-0.98	-0.55	-0.98	-0.67	-0.8	-0.83	-0.85	-0.75	-0.83	0.74	-0.69	-0.42	-0.79	-0.8	-0.46
Retained Earnings	-0.96	-0.64	-0.84	-0.9	-0.99	-0.64	-0.97	-0.76	0.77		-0.92	-0.83	-0.92	-0.66	-0.34	-0.89	-0.94	-0.93	-0.92	-0.79	0.59	-0.99	-0.87	-0.95	-0.97	-0.75
Accounts Payable	0.83	0.73	0.62	0.77	0.93	0.55	0.95	0.93	-0.54	-0.92		0.67	0.83	0.43	0.21	0.85	0.84	0.81	0.79	0.69	-0.57	0.95	0.98	0.86	0.83	0.62
Cash	0.81	0.73	0.72	0.84	0.8	0.86	0.83	0.36	-0.98	-0.83	0.67		0.61	0.95	0.63	0.88	0.88	0.88	0.76	0.87	-0.8	0.78	0.55	0.84	0.83	0.45
Non Current Assets Total	0.88	0.37	0.76	0.73	0.93	0.41	0.85	0.79	-0.55	-0.92	0.83	0.61		0.43	0.21	0.72	0.77	0.79	0.83	0.58	-0.3	0.94	0.85	0.82	0.87	0.78
Non Currrent Assets Other	0.69	0.63	0.61	0.73	0.61	0.86	0.65	0.09	-0.98	-0.66	0.43	0.95	0.43		0.76	0.75	0.75	0.79	0.64	0.81	-0.74	0.58	0.31	0.72	0.72	0.32
Other Assets	0.36	0.37	0.17	0.39	0.29	0.57	0.3	-0.05	-0.67	-0.34	0.21	0.63	0.21	0.76		0.37	0.34	0.46	0.44	0.42	-0.42	0.27	0.13	0.37	0.38	0.14
Long Term Debt	0.86	0.88	0.64	0.77	0.9	0.89	0.95	0.65	-0.8	-0.89	0.85	0.88	0.72	0.75	0.37		0.93	0.94	0.7	0.95	-0.8	0.89	0.79	0.93	0.87	0.39
Cash And Short Term Investments	0.97	0.78	0.85	0.93	0.93	0.77	0.95	0.63	-0.83	-0.94	0.84	0.88	0.77	0.75	0.34	0.93		0.98	0.85	0.92	-0.72	0.92	0.76	0.98	0.97	0.65
Common Stock Total Equity	0.97	0.79	0.77	0.88	0.92	0.84	0.93	0.6	-0.85	-0.93	0.81	0.88	0.79	0.79	0.46	0.94	0.98		0.84	0.94	-0.69	0.9	0.75	0.99	0.97	0.59
Common Stock Shares Outstanding	0.92	0.5	0.83	0.9	0.86	0.5	0.83	0.62	-0.75	-0.92	0.79	0.76	0.83	0.64	0.44	0.7	0.85	0.84		0.65	-0.44	0.87	0.73	0.87	0.92	0.83
Long Term Debt Total	0.84	0.89	0.62	0.75	0.79	0.95	0.85	0.46	-0.83	-0.79	0.69	0.87	0.58	0.81	0.42	0.95	0.92	0.94	0.65		-0.79	0.77	0.62	0.91	0.85	0.32
Non Current Liabilities Total	-0.55	-0.83	-0.47	-0.66	-0.6	-0.8	-0.71	-0.31	0.74	0.59	-0.57	-0.8	-0.3	-0.74	-0.42	-0.8	-0.72	-0.69	-0.44	-0.79		-0.58	-0.47	-0.65	-0.58	-0.05
Capital Surpluse	0.94	0.65	0.8	0.86	1.0	0.61	0.98	0.83	-0.69	-0.99	0.95	0.78	0.94	0.58	0.27	0.89	0.92	0.9	0.87	0.77	-0.58		0.92	0.93	0.94	0.71
Capital Lease Obligations	0.78	0.65	0.55	0.68	0.91	0.47	0.9	0.97	-0.42	-0.87	0.98	0.55	0.85	0.31	0.13	0.79	0.76	0.75	0.73	0.62	-0.47	0.92		0.81	0.78	0.59
Other Current Assets	0.98	0.78	0.79	0.89	0.94	0.78	0.95	0.68	-0.79	-0.95	0.86	0.84	0.82	0.72	0.37	0.93	0.98	0.99	0.87	0.91	-0.65	0.93	0.81		0.98	0.65
Other Stockholder Equity	1.0	0.66	0.87	0.92	0.94	0.7	0.93	0.65	-0.8	-0.97	0.83	0.83	0.87	0.72	0.38	0.87	0.97	0.97	0.92	0.85	-0.58	0.94	0.78	0.98		0.74
Total Liab	0.76	0.12	0.83	0.78	0.69	0.09	0.62	0.56	-0.46	-0.75	0.62	0.45	0.78	0.32	0.14	0.39	0.65	0.59	0.83	0.32	-0.05	0.71	0.59	0.65	0.74

Click cells to compare fundamentals

Axonics Modulation Account Relationship Matchups

Axonics Modulation fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	219.8M	342.2M	547.9M	659.4M	719.9M	371.4M
Short Long Term Debt Total	25.4M	31.5M	10.4M	9.1M	27.6M	17.6M
Other Current Liab	5.5M	12.6M	17.8M	54.6M	25.6M	16.4M
Total Current Liabilities	12.0M	45.7M	26.9M	65.2M	45.8M	28.2M
Total Stockholder Equity	183.0M	287.4M	482.4M	570.1M	637.6M	669.4M
Net Tangible Assets	182.7M	287.2M	270.5M	389.5M	447.9M	470.3M
Property Plant And Equipment Net	3.0M	6.3M	6.9M	6.8M	33.3M	34.9M
Net Debt	(145.7M)	(209.6M)	(210.5M)	(229.7M)	(77.2M)	(81.1M)
Retained Earnings	(179.6M)	(234.5M)	(314.6M)	(374.3M)	(380.4M)	(361.3M)
Accounts Payable	5.9M	10.7M	7.7M	9.1M	18.5M	19.4M
Cash	171.1M	241.2M	220.9M	238.8M	104.8M	152.3M
Non Current Assets Total	8.1M	14.3M	226.6M	194.3M	228.5M	239.9M
Non Currrent Assets Other	4.8M	7.7M	7.7M	6.8M	1.7M	1.6M
Other Assets	584K	7.7M	7.7M	613K	1.0	0.95
Cash And Short Term Investments	183.7M	241.2M	220.9M	357.2M	345.0M	211.5M
Common Stock Shares Outstanding	28.6M	37.0M	43.1M	46.7M	49.1M	34.2M
Liabilities And Stockholders Equity	219.8M	342.2M	547.9M	659.4M	719.9M	371.4M
Non Current Liabilities Total	24.8M	9.2M	38.6M	24.0M	36.5M	26.4M
Capital Surpluse	363.0M	522.3M	803.6M	969.5M	1.1B	1.2B
Capital Lease Obligations	5.1M	10.4M	10.4M	9.1M	27.6M	29.0M
Inventory	15.7M	63.1M	64.9M	55.8M	79.9M	83.9M
Other Current Assets	4.5M	5.4M	6.4M	7.3M	9.3M	5.2M
Other Stockholder Equity	363.0M	522.3M	803.6M	969.5M	1.0B	541.4M
Total Liab	36.8M	54.8M	65.5M	89.2M	82.4M	64.5M
Property Plant And Equipment Gross	3.0M	6.3M	12.5M	14.3M	21.6M	22.7M
Total Current Assets	211.7M	327.9M	321.3M	465.1M	491.4M	277.5M
Accumulated Other Comprehensive Income	(428K)	(431K)	(6.6M)	(25.1M)	(15.9M)	(15.1M)
Intangible Assets	311K	196K	106.5M	86.3M	81.4M	85.4M
Property Plant Equipment	7.2M	6.3M	6.9M	6.8M	7.8M	5.7M
Net Receivables	7.9M	18.3M	29.0M	44.8M	57.2M	60.1M
Net Invested Capital	203.3M	308.5M	482.4M	602.7M	637.6M	366.3M
Net Working Capital	199.6M	282.3M	294.4M	399.8M	445.6M	283.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
V	Visa Class A
MSFT	Microsoft

Additional Tools for Axonics Stock Analysis

When running Axonics Modulation's price analysis, check to measure Axonics Modulation's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axonics Modulation is operating at the current time. Most of Axonics Modulation's value examination focuses on studying past and present price action to predict the probability of Axonics Modulation's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axonics Modulation's price. Additionally, you may evaluate how the addition of Axonics Modulation to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Axonics Long Term Debt vs Deferred Long Term Liab Analysis

Long Term Debt vs Deferred Long Term Liab

Long Term Debt vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Long Term Debt

Deferred Long Term Liab

Axonics Modulation fundamental ratios Correlations

Axonics Modulation Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Axonics Modulation fundamental ratios Accounts

Also Currently Popular

Additional Tools for Axonics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Stockholder Equity	+ 1.0	Total Assets
Capital Surpluse	+ 1.0	Total Stockholder Equity
Other Current Assets	+ 0.99	Common Stock Total Equity
Other Current Assets	+ 0.98	Total Assets
Net Tangible Assets	+ 0.98	Total Stockholder Equity
Capital Surpluse	+ 0.98	Net Tangible Assets

Capital Surpluse	- 0.99	Retained Earnings
Retained Earnings	- 0.99	Total Stockholder Equity
Non Currrent Assets Other	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Other Stockholder Equity	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Net Tangible Assets